Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Stigma as a Barrier to HBV Care: Patient and Physician Sharing Session #2

In episode 2 of this ongoing series, listen to a conversation between Robert G. Gish, MD, FAASLD, and patient and advocate, Alan Wang, on approaches to destigmatize HBV infection and remove barriers to care.
Robert G. Gish, MD
Released: April 12, 2021

In episode 2 of an ongoing series of sharing sessions between a physician and patient, Robert Gish, MD, FAASLD, and patient advocate, Alan Wang, discuss stigma as a barrier to optimal HBV care and treatment. The conversation focuses on how stigma affected Alan’s engagement with his care and strategies to overcome stigma as a barrier to HBV care.


Robert Gish, MD, FAASLD
Medical Director
Hepatitis B Foundation
Medical Director
Asian Pacific Health Foundation 
San Diego, California


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from:
Gilead Sciences, Inc.

Related Content

Brief presentation by Dr. Anna Christina dela Cruz on the various methods to assess liver inflammation and fibrosis and translating results into practice from Clinical Care Options (CCO)

Anna Christina L. dela Cruz, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 20, 2021 Expired: April 19, 2022

Download free slides reviewing key data and AASLD guidance on methods to evaluate liver fibrosis and inflammation in patients with HBV infection

Anna Christina L. dela Cruz, MD Released: April 20, 2021

W. Grace L. H. Wong 博士,来自 Clinical Care Options (CCO)的慢性 HBV 患者的 HCC 风险评估和跨学科管理

Grace LH Wong, 医学博士 Released: April 16, 2021

Clinical Care Options (CCO) expert commentary on incorporating family history into clinical decision-making when caring for patients with hepatitis B

Anna Christina L. dela Cruz, MD Released: April 15, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.